HRIBF(HRIBF)
HRIBF
No analyst ratings available
No analyst price targets available for HRIBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $372.44B | $404.18B | $426.94B | $448.83B | $466.48B |
| Low | $350.43B | $366.71B | $394.27B | $414.48B | $430.78B |
| High | $382.65B | $426.23B | $444.65B | $467.44B | $485.83B |
| EBITDA Avg | $76.22B | $82.71B | $87.37B | $91.85B | $95.46B |
| Low | $71.71B | $75.04B | $80.68B | $84.82B | $88.16B |
| High | $78.30B | $87.22B | $90.99B | $95.66B | $99.42B |
| EBIT Avg | $62.79B | $68.15B | $71.98B | $75.67B | $78.65B |
| Low | $59.08B | $61.83B | $66.47B | $69.88B | $72.63B |
| High | $64.52B | $71.86B | $74.97B | $78.81B | $81.91B |
| Net Income Avg | $48.73B | $57.00B | $63.35B | $70.85B | $74.15B |
| Low | $43.88B | $51.33B | $57.05B | $63.80B | $66.78B |
| High | $51.36B | $60.07B | $66.77B | $74.67B | $78.15B |
| EPS Avg | $1155.21 | $1351.16 | $1501.90 | $1679.49 | $1757.92 |
| Low | $1040.28 | $1216.73 | $1352.47 | $1512.40 | $1583.02 |
| High | $1217.49 | $1424.01 | $1582.87 | $1770.05 | $1852.70 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 4 / 1 | 3 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $92.74B | $114.74B |
| Low | $92.04B | $113.87B |
| High | $93.34B | $115.49B |
| EBITDA Avg | $18.98B | $23.48B |
| Low | $18.83B | $23.30B |
| High | $19.10B | $23.63B |
| EBIT Avg | $15.64B | $19.35B |
| Low | $15.52B | $19.20B |
| High | $15.74B | $19.47B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 3 / — | 2 / — |